Loading…

Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence

Background Many studies have reported the predictors of atrial fibrillation (AF) recurrence after persistent AF (peAF) ablation. However, the correlation between the atrial defibrillation threshold (DFT) for internal cardioversion (IC) and AF recurrence rate is unknown. Here we investigated the rela...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cardiology (Mahwah, N.J.) N.J.), 2021-08, Vol.44 (8), p.1169-1176
Main Authors: Sawasaki, Kohei, Inden, Yasuya, Hosoya, Natsuko, Muto, Masahiro, Murohara, Toyoaki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4879-af0dc4ce30df2e39807c3ab3b4c4d34cc3321e9b66f1b2c9af55989e33214b8b3
cites cdi_FETCH-LOGICAL-c4879-af0dc4ce30df2e39807c3ab3b4c4d34cc3321e9b66f1b2c9af55989e33214b8b3
container_end_page 1176
container_issue 8
container_start_page 1169
container_title Clinical cardiology (Mahwah, N.J.)
container_volume 44
creator Sawasaki, Kohei
Inden, Yasuya
Hosoya, Natsuko
Muto, Masahiro
Murohara, Toyoaki
description Background Many studies have reported the predictors of atrial fibrillation (AF) recurrence after persistent AF (peAF) ablation. However, the correlation between the atrial defibrillation threshold (DFT) for internal cardioversion (IC) and AF recurrence rate is unknown. Here we investigated the relationship between the DFT prior to catheter ablation for peAF and AF recurrence. Hypothesis DFT prior to ablation was the predictive factor for AF recurrence after peAF ablation. Methods From June 2016 to May 2019, we enrolled 82 consecutive patients (mean age, 65.0 ± 12.4 years), including 45 with peAF and 37 with long‐standing peAF, at Hamamatsu Medical Center. To assess the DFT, we performed IC with gradually increasing energy prior to radiofrequency application. Results Forty‐nine and 33 patients showed DFT values less than or equal to 10 J (group A) and greater than 10 J or unsuccessful defibrillation (group B). During the mean follow‐up duration of 20.5 ± 13.1 months, patients in group B showed significantly higher AF recurrence rates than those in group A after the ablation procedure (p = .017). Multivariate analysis revealed that DFT was the only predictive factor for AF recurrence (odds ratio, 1.07; 95% CI, 1.00–1.13, p = .047). Conclusions The DFT for IC was among the strongest prognostic factors in the peAF ablation procedure.
doi_str_mv 10.1002/clc.23679
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8364735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A710567102</galeid><sourcerecordid>A710567102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4879-af0dc4ce30df2e39807c3ab3b4c4d34cc3321e9b66f1b2c9af55989e33214b8b3</originalsourceid><addsrcrecordid>eNp1kk2LFDEQhoMo7uzqwX_Q4EUPPZuv7iQXYRk_YcCLnkO6unonS6YzJt0r--837QzKiBJIoOp530olRcgrRteMUn4NAdZctMo8IStmBK-1EuopWVHW0tpwbS7IZc53BaWai-fkQsiS0VyvSHiPg--SD8FNPo7VtEuYdzH0VRwqP06YRhcqcKn38R5TXphD8jFVU6xcd1IdEvYeply5KfnCn1kmhDklHAFfkGeDCxlfns4r8v3jh2-bz_X266cvm5ttDVIrU7uB9iABBe0HjsJoqkC4TnQSZC8kgBCcoenadmAdB-OGpjHa4BKWne7EFXl39D3M3R57wHFKLthy771LDzY6b88zo9_Z23hvtWilEk0xeHMySPHHjHmye58BS0cjxjlb3kgpS02mCvr6L_QuzsujLVTLOFXlsf9Qty6g9eMQS11YTO2NYrRpy8YLtf4HVVaPew9xLF9V4meCt0cBpJhzwuF3j4zaZTRsGQ37azQKe31kfxaTh_-DdrPdHBWPID-6sg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561207341</pqid></control><display><type>article</type><title>Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Sawasaki, Kohei ; Inden, Yasuya ; Hosoya, Natsuko ; Muto, Masahiro ; Murohara, Toyoaki</creator><creatorcontrib>Sawasaki, Kohei ; Inden, Yasuya ; Hosoya, Natsuko ; Muto, Masahiro ; Murohara, Toyoaki</creatorcontrib><description>Background Many studies have reported the predictors of atrial fibrillation (AF) recurrence after persistent AF (peAF) ablation. However, the correlation between the atrial defibrillation threshold (DFT) for internal cardioversion (IC) and AF recurrence rate is unknown. Here we investigated the relationship between the DFT prior to catheter ablation for peAF and AF recurrence. Hypothesis DFT prior to ablation was the predictive factor for AF recurrence after peAF ablation. Methods From June 2016 to May 2019, we enrolled 82 consecutive patients (mean age, 65.0 ± 12.4 years), including 45 with peAF and 37 with long‐standing peAF, at Hamamatsu Medical Center. To assess the DFT, we performed IC with gradually increasing energy prior to radiofrequency application. Results Forty‐nine and 33 patients showed DFT values less than or equal to 10 J (group A) and greater than 10 J or unsuccessful defibrillation (group B). During the mean follow‐up duration of 20.5 ± 13.1 months, patients in group B showed significantly higher AF recurrence rates than those in group A after the ablation procedure (p = .017). Multivariate analysis revealed that DFT was the only predictive factor for AF recurrence (odds ratio, 1.07; 95% CI, 1.00–1.13, p = .047). Conclusions The DFT for IC was among the strongest prognostic factors in the peAF ablation procedure.</description><identifier>ISSN: 0160-9289</identifier><identifier>EISSN: 1932-8737</identifier><identifier>DOI: 10.1002/clc.23679</identifier><identifier>PMID: 34160828</identifier><language>eng</language><publisher>New York: Wiley Periodicals, Inc</publisher><subject>Ablation ; Ablation (Surgery) ; Analysis ; Anticoagulants ; Anticoagulants (Medicine) ; atrial defibrillation threshold ; Atrial fibrillation ; Cardiac arrhythmia ; Cardioversion ; catheter ablation ; Catheters ; Clinical Investigations ; Diabetes ; Ejection fraction ; Electric countershock ; Electrocardiography ; Laboratories ; Medical centers ; Medical prognosis ; Patients ; Peptides ; persistent atrial fibrillation ; Prognosis ; Statistical analysis ; Veins &amp; arteries</subject><ispartof>Clinical cardiology (Mahwah, N.J.), 2021-08, Vol.44 (8), p.1169-1176</ispartof><rights>2021 The Authors. published by Wiley Periodicals LLC.</rights><rights>COPYRIGHT 2021 John Wiley &amp; Sons, Inc.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4879-af0dc4ce30df2e39807c3ab3b4c4d34cc3321e9b66f1b2c9af55989e33214b8b3</citedby><cites>FETCH-LOGICAL-c4879-af0dc4ce30df2e39807c3ab3b4c4d34cc3321e9b66f1b2c9af55989e33214b8b3</cites><orcidid>0000-0003-4981-9765</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2561207341/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2561207341?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Sawasaki, Kohei</creatorcontrib><creatorcontrib>Inden, Yasuya</creatorcontrib><creatorcontrib>Hosoya, Natsuko</creatorcontrib><creatorcontrib>Muto, Masahiro</creatorcontrib><creatorcontrib>Murohara, Toyoaki</creatorcontrib><title>Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence</title><title>Clinical cardiology (Mahwah, N.J.)</title><description>Background Many studies have reported the predictors of atrial fibrillation (AF) recurrence after persistent AF (peAF) ablation. However, the correlation between the atrial defibrillation threshold (DFT) for internal cardioversion (IC) and AF recurrence rate is unknown. Here we investigated the relationship between the DFT prior to catheter ablation for peAF and AF recurrence. Hypothesis DFT prior to ablation was the predictive factor for AF recurrence after peAF ablation. Methods From June 2016 to May 2019, we enrolled 82 consecutive patients (mean age, 65.0 ± 12.4 years), including 45 with peAF and 37 with long‐standing peAF, at Hamamatsu Medical Center. To assess the DFT, we performed IC with gradually increasing energy prior to radiofrequency application. Results Forty‐nine and 33 patients showed DFT values less than or equal to 10 J (group A) and greater than 10 J or unsuccessful defibrillation (group B). During the mean follow‐up duration of 20.5 ± 13.1 months, patients in group B showed significantly higher AF recurrence rates than those in group A after the ablation procedure (p = .017). Multivariate analysis revealed that DFT was the only predictive factor for AF recurrence (odds ratio, 1.07; 95% CI, 1.00–1.13, p = .047). Conclusions The DFT for IC was among the strongest prognostic factors in the peAF ablation procedure.</description><subject>Ablation</subject><subject>Ablation (Surgery)</subject><subject>Analysis</subject><subject>Anticoagulants</subject><subject>Anticoagulants (Medicine)</subject><subject>atrial defibrillation threshold</subject><subject>Atrial fibrillation</subject><subject>Cardiac arrhythmia</subject><subject>Cardioversion</subject><subject>catheter ablation</subject><subject>Catheters</subject><subject>Clinical Investigations</subject><subject>Diabetes</subject><subject>Ejection fraction</subject><subject>Electric countershock</subject><subject>Electrocardiography</subject><subject>Laboratories</subject><subject>Medical centers</subject><subject>Medical prognosis</subject><subject>Patients</subject><subject>Peptides</subject><subject>persistent atrial fibrillation</subject><subject>Prognosis</subject><subject>Statistical analysis</subject><subject>Veins &amp; arteries</subject><issn>0160-9289</issn><issn>1932-8737</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1kk2LFDEQhoMo7uzqwX_Q4EUPPZuv7iQXYRk_YcCLnkO6unonS6YzJt0r--837QzKiBJIoOp530olRcgrRteMUn4NAdZctMo8IStmBK-1EuopWVHW0tpwbS7IZc53BaWai-fkQsiS0VyvSHiPg--SD8FNPo7VtEuYdzH0VRwqP06YRhcqcKn38R5TXphD8jFVU6xcd1IdEvYeply5KfnCn1kmhDklHAFfkGeDCxlfns4r8v3jh2-bz_X266cvm5ttDVIrU7uB9iABBe0HjsJoqkC4TnQSZC8kgBCcoenadmAdB-OGpjHa4BKWne7EFXl39D3M3R57wHFKLthy771LDzY6b88zo9_Z23hvtWilEk0xeHMySPHHjHmye58BS0cjxjlb3kgpS02mCvr6L_QuzsujLVTLOFXlsf9Qty6g9eMQS11YTO2NYrRpy8YLtf4HVVaPew9xLF9V4meCt0cBpJhzwuF3j4zaZTRsGQ37azQKe31kfxaTh_-DdrPdHBWPID-6sg</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Sawasaki, Kohei</creator><creator>Inden, Yasuya</creator><creator>Hosoya, Natsuko</creator><creator>Muto, Masahiro</creator><creator>Murohara, Toyoaki</creator><general>Wiley Periodicals, Inc</general><general>John Wiley &amp; Sons, Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4981-9765</orcidid></search><sort><creationdate>202108</creationdate><title>Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence</title><author>Sawasaki, Kohei ; Inden, Yasuya ; Hosoya, Natsuko ; Muto, Masahiro ; Murohara, Toyoaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4879-af0dc4ce30df2e39807c3ab3b4c4d34cc3321e9b66f1b2c9af55989e33214b8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Ablation (Surgery)</topic><topic>Analysis</topic><topic>Anticoagulants</topic><topic>Anticoagulants (Medicine)</topic><topic>atrial defibrillation threshold</topic><topic>Atrial fibrillation</topic><topic>Cardiac arrhythmia</topic><topic>Cardioversion</topic><topic>catheter ablation</topic><topic>Catheters</topic><topic>Clinical Investigations</topic><topic>Diabetes</topic><topic>Ejection fraction</topic><topic>Electric countershock</topic><topic>Electrocardiography</topic><topic>Laboratories</topic><topic>Medical centers</topic><topic>Medical prognosis</topic><topic>Patients</topic><topic>Peptides</topic><topic>persistent atrial fibrillation</topic><topic>Prognosis</topic><topic>Statistical analysis</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sawasaki, Kohei</creatorcontrib><creatorcontrib>Inden, Yasuya</creatorcontrib><creatorcontrib>Hosoya, Natsuko</creatorcontrib><creatorcontrib>Muto, Masahiro</creatorcontrib><creatorcontrib>Murohara, Toyoaki</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cardiology (Mahwah, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sawasaki, Kohei</au><au>Inden, Yasuya</au><au>Hosoya, Natsuko</au><au>Muto, Masahiro</au><au>Murohara, Toyoaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence</atitle><jtitle>Clinical cardiology (Mahwah, N.J.)</jtitle><date>2021-08</date><risdate>2021</risdate><volume>44</volume><issue>8</issue><spage>1169</spage><epage>1176</epage><pages>1169-1176</pages><issn>0160-9289</issn><eissn>1932-8737</eissn><abstract>Background Many studies have reported the predictors of atrial fibrillation (AF) recurrence after persistent AF (peAF) ablation. However, the correlation between the atrial defibrillation threshold (DFT) for internal cardioversion (IC) and AF recurrence rate is unknown. Here we investigated the relationship between the DFT prior to catheter ablation for peAF and AF recurrence. Hypothesis DFT prior to ablation was the predictive factor for AF recurrence after peAF ablation. Methods From June 2016 to May 2019, we enrolled 82 consecutive patients (mean age, 65.0 ± 12.4 years), including 45 with peAF and 37 with long‐standing peAF, at Hamamatsu Medical Center. To assess the DFT, we performed IC with gradually increasing energy prior to radiofrequency application. Results Forty‐nine and 33 patients showed DFT values less than or equal to 10 J (group A) and greater than 10 J or unsuccessful defibrillation (group B). During the mean follow‐up duration of 20.5 ± 13.1 months, patients in group B showed significantly higher AF recurrence rates than those in group A after the ablation procedure (p = .017). Multivariate analysis revealed that DFT was the only predictive factor for AF recurrence (odds ratio, 1.07; 95% CI, 1.00–1.13, p = .047). Conclusions The DFT for IC was among the strongest prognostic factors in the peAF ablation procedure.</abstract><cop>New York</cop><pub>Wiley Periodicals, Inc</pub><pmid>34160828</pmid><doi>10.1002/clc.23679</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4981-9765</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-9289
ispartof Clinical cardiology (Mahwah, N.J.), 2021-08, Vol.44 (8), p.1169-1176
issn 0160-9289
1932-8737
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8364735
source Wiley Online Library Open Access; Publicly Available Content Database; PubMed Central
subjects Ablation
Ablation (Surgery)
Analysis
Anticoagulants
Anticoagulants (Medicine)
atrial defibrillation threshold
Atrial fibrillation
Cardiac arrhythmia
Cardioversion
catheter ablation
Catheters
Clinical Investigations
Diabetes
Ejection fraction
Electric countershock
Electrocardiography
Laboratories
Medical centers
Medical prognosis
Patients
Peptides
persistent atrial fibrillation
Prognosis
Statistical analysis
Veins & arteries
title Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A38%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defibrillation%20threshold%20of%20internal%20cardioversion%20prior%20to%20ablation%20predicts%20atrial%20fibrillation%20recurrence&rft.jtitle=Clinical%20cardiology%20(Mahwah,%20N.J.)&rft.au=Sawasaki,%20Kohei&rft.date=2021-08&rft.volume=44&rft.issue=8&rft.spage=1169&rft.epage=1176&rft.pages=1169-1176&rft.issn=0160-9289&rft.eissn=1932-8737&rft_id=info:doi/10.1002/clc.23679&rft_dat=%3Cgale_pubme%3EA710567102%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4879-af0dc4ce30df2e39807c3ab3b4c4d34cc3321e9b66f1b2c9af55989e33214b8b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2561207341&rft_id=info:pmid/34160828&rft_galeid=A710567102&rfr_iscdi=true